You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

NAP2 293T Transfected Lysate - (positive control) (ab94141)

Submit a Question

Overview

  • Product nameNAP2 293T Transfected Lysate - (positive control)
  • General notesab94141 is a 293T cell transfected lysate in which Human NAP2 has been transiently over-expressed using a pCMV-NAP2 plasmid. The lysate is provided in 1 x Sample Buffer. Note: For more details about how the transfected lysate was prepared view preparation notes
  • Tested applicationsWB more details

Properties

  • BackgroundFunction: LA-PF4 stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan. It also stimulates the formation and secretion of plasminogen activator by human synovial cells. NAP-2 is a ligand for CXCR1 and CXCR2, and NAP-2, NAP-2(73), NAP-2(74), NAP-2(1-66), and most potent NAP-2(1-63) are chemoattractants and activators for neutrophils. TC-1 and TC-2 are antibacterial proteins, in vitro released from activated platelet alpha-granules. CTAP-III(1-81) is more potent than CTAP-III desensitize chemokine-induced neutrophil activation. Similarity: Belongs to the intercrine alpha (chemokine CxC) family. PTM: Proteolytic removal of residues 1-9 produces the active peptide connective tissue-activating peptide III (CTAP-III) (low-affinity platelet factor IV (LA-PF4)). Proteolytic removal of residues 1-13 produces the active peptide beta-thromboglobulin, which is released from platelets along with platelet factor 4 and platelet-derived growth factor. NAP-2(1-66) is produced by proteolytical processing, probably after secretion by leukocytes other than neutrophils. NAP-2(73) and NAP-2(74) seem not be produced by proteolytical processing of secreted precursors but are released in an active form from platelets.

    • Applications

    Our Abpromise guarantee covers the use of ab94141 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Notes
    WB
  • Application notesWB: Use at an assay dependent dilution.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.

    • NAP2 293T Transfected Lysate - (positive control) images

    • SDS-PAGE - NAP2 293T Transfected Lysate - (positive control) (ab94141)
      SDS-PAGE - NAP2 293T Transfected Lysate - (positive control) (ab94141)
      ab94141 at 15µg/lane on an SDS-PAGE gel.
    • Western blot - NAP2 293T Transfected Lysate - (positive control) (ab94141)
      Western blot - NAP2 293T Transfected Lysate - (positive control) (ab94141)
      All lanes : Anti-NAP2 antibody (ab58142) at 1/500 dilution

      Lane 1 : NAP2 293T Transfected Lysate - (positive control) (ab94141)
      Lane 2 : 293T non-transfected lysate

      Lysates/proteins at 25 µg per lane.

      Secondary
      Goat Anti-mouse IgG (H and L) HRP conjugated at 1/2500 dilution

    References for NAP2 293T Transfected Lysate - (positive control) (ab94141)

    ab94141 has not yet been referenced specifically in any publications.

    Publishing research using ab94141 ? Please let us know so that we can cite the reference in this datasheet

    Product Wall

    Submit a Question for ab94141

    There are currently no Questions for ab94141.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"